Non Fungible Tokens (NFTs) have recently gained traction, with art and entertainment acting as the pioneer sectors responsible for popularising NFTs. Fortune 500 companies, the sports world –to list a few, have all swapped into the NFT ecosystem, leading to massive adoption in recent times. The incorporation of this unique use case with several sectors has also shown how blockchain technology is reshaping –not just the financial system but other relevant aspects of living.
NFT concept has also made its way to the health care sector as the phenomenal use case continues to revolutionise the world at large. NFTs can help e-health thrive in our modernised century –the evidence and advantages of NFTs in the health industry are like a giant balloon so high up in the sky and very visible, just as its benefits are in the entertainment industry.
And as the market evolves, we see an increased use of NFTs in both the manufacturing, logistics and supply chain, data transfer (especially as digital healthcare technologies surge), patient-centric data management and potentially in mergers and acquisitions (M&As) of pharmaceutical and technology companies, etc.
Aimedis –a Blockchain-enabled Health data platform that aims to make eHealth secure, affordable, and accessible globally by combining health data, online prescriptions, and video consultation with doctors in one single platform and multiple languages. It is said to have a cutting-edge ecosystem designed to benefit everyone.
The depiction of health data is one of the most potential applications of NFTs in healthcare, and with the introduction of Aimedis, this goes further to prove the advancement of NFTs in our health organisation. Peculiarly, with NFTs intention of being an equivalent of a certificate of authenticity, making it easier for every healthcare professional to carry with them their credentials as non-fungible tokens in their wallet.
Aimedis is one of NFTs innovative solutions to the health care sector. Based on blockchain technology, it aims to bring together a range of e-health applications –including prescriptions, medical records, video chats, appointments and second opinions — all while allowing patients to connect the smartwatches that store their data. With the company’s intentions to launch a virtual hospital and rehab, with a modern hospital information system that is less expensive than the status quo, it would be a much more straightforward approach for patients to keep in touch with doctors and specialists without getting into a physical hospital.
With NFTs application on pharmaceutical manufacturing, identifying a specific batch of medications, tracing, and authentication processes would be made much more accessible. Prescription orders could likewise be linked to an NFT, which allows for easy identification of who issued them and the prevention of faked prescriptions. Aimedis proposes converting anonymised medical data into NFTs, which can then be purchased by pharmaceutical companies or used for machine learning as artificial intelligence is increasingly used to deliver better patient outcomes.
The use of NFTs for blood donations is already encouraged by blood donation organisations. Aimedis fellow co-founder Michael J Kaldasch said that the company plans to turn medical data into NFTs with a standardised structure with a platform that allows tokens to be sold for a fixed price or at auctions. It’s hoped that this could open new revenue streams for patients –especially those in poorer regions.
With the many benefits that Aimedis offers, it’s easy to say that NFTs aren’t only for artwork and its likes. This proves how much impact NFTs are on the long-overdue health industry.